Skip to main content

Table 1 Results from data mining using GDC Data Portal, COSMIC, and cBioPortal are summarized here. The percentages of mutations in Direct DNA Repair genes and genes involved in Indirect DNA Stability as well as death rates in the TCGA BLCA tissue cohort are reported.

From: PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth

Direct DNA Repair

COSMIC

GDC Data Portal

cBioPortal

Death Rates (GDC Data Portal)

ATM

7.91%

15.63%

9%

Unavailable

ERCC2

7.46%

12.67%

10%

Unavailable

BRCA2

6.09%

12.40%

7%

Unavailable

ATR

1.19%

10.24%

5%

Unavailable

PRKDC

0

9.43%

8%

Unavailable

POLE

1.49%

7.28%

5%

Unavailable

FANCD2

1.64%

7.01%

9%

Unavailable

FANCA

2.24%

6.74%

6%

Unavailable

SLX4

1.64%

6.47%

5%

Unavailable

FANCM

1.49%

6.20%

4%

Unavailable

BRIP1

1.64%

5.93%

5%

Unavailable

BRCA1

1.94%

5.66%

5%

Unavailable

OGG1

0.30%

3.50%

7%

Unavailable

NBN

1.19%

3.23%

6%

Unavailable

RAD54B

1.04%

1.89%

6%

Unavailable

DCLRE1C

0.30%

1.89%

5%

Unavailable

XPC

0.30%

1.62%

5%

Unavailable

NEIL2

0.15%

1.35%

6%

Unavailable

Indirect DNA Stability

    

TP53

28%

55.26%

48%

44.39%

POLQ

1.49%

10.24%

5%

36.84%

CDK12

1.64%

8.63%

6%

37.50%

REV3L

1.49%

7.55%

5%

32.14%

TP53BP1

1.34%

7.01%

5%

26.92%

CENPE

2.39%

6.47%

4%

41.67%

MDC1

2.09%

6.47%

5%

33.33%

KNTC1

1.34%

5.39%

5%

40%

BUB1

1.04%

5.12%

5%

21.05%

RNF168

1.34%

4.04%

5%

26.67%

BAP1

1.34%

4.04%

5%

40%

RECQL4

0.45%

4.04%

5%

40%

POLN

1.04%

3.77%

5%

28.57%

CLK2

0.30%

3.50%

5%

23.08%

WRN

1.19%

2.96%

5%

36.36%

RRM2B

0

1.35%

9%

40%

TDP2

0.15%

1.08%

5%

25%

RAD18

0.45%

0.81%

6%

33.33%

RAD1

0.30%

0.81%

6%

100%

POLB

0

0.27%

5%

0%